Nature Communications (Feb 2022)
A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis
Abstract
Hexokinase 2 expression is markedly induced in cancer cells and contributes to cancer cell metabolism. Here, the authors show that hexokinase 2 can contribute to the metastatic spread of cancer cells independently of its glycolytic function via inhibiting the activity of GSK3β, which in turn elevates the protein levels of the EMT transcription factor SNAIL.